- Home
- RCUS vs DHT Comparison
RCUS vs DHT Comparison
Compare RCUS & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | DHT |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RCUS | DHT |
|---|---|---|
| Price | $17.47 | $22.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $41.00 | $26.73 |
| AVG Volume (30 Days) | 2.4M | ★ 5.2M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 8.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $138.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.43 | $11.64 |
| 52 Week High | $31.74 | $26.91 |
Technical Indicators
Market Signals| Indicator | RCUS | DHT |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 47.15 |
| Support Level | N/A | $16.83 |
| Resistance Level | $19.63 | $23.56 |
| Average True Range (ATR) | 0.95 | 1.03 |
| MACD | 0.16 | -0.22 |
| Stochastic Oscillator | 10.96 | 50.00 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.